Exchange: NASDAQ·Updated 07:30 PM EDT
KNSA logo

KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

$75.15
$1.43
(1.87%)
Today
Closed $75.15
$0.00
(0.00%)
After Hours
EarningsOct 27
Mkt Cap$5.98B
Vol488,920.00

About KNSA

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
56

Bullish Sentiment

How do you feel about KNSA?

Advertisement|Remove ads.